The impact of urate-lowering therapy on kidney function (IMPULsKF)
The concept of trial launched in Ukraine in 2017 with POEM design and 36-months duration is presented. It aims to investigate the impact of two target levels of urate-lowering therapy caused by hyperuricemia on kidney function and chronic kidney disease (CKD) progression measured by estimated glomer...
Main Author: | D.D. Ivanov |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House Zaslavsky
2017-04-01
|
Series: | Počki |
Subjects: | |
Online Access: | http://kidneys.zaslavsky.com.ua/article/view/102786 |
Similar Items
-
Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study
by: Matthew Roughley, et al.
Published: (2018-10-01) -
Treatment approaches and adherence to urate-lowering therapy for patients with gout
by: Aung T, et al.
Published: (2017-04-01) -
Prevention of arthritis attacks in the use of urate-lowering therapy in patients with gout
by: M. N. Chikina
Published: (2019-01-01) -
Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients
by: Ting-Ting Chung, et al.
Published: (2019-09-01) -
The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trial
by: Lisa K. Stamp, et al.
Published: (2017-12-01)